Cancer of the Larynx

Cancer Epidemiology and Prevention

Volumn , Issue , 2009, Pages

  Olshan, Andrew F ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Cancer epidemiology; Cancer prevention; Cancer risk; Laryngeal cancer; Squamous cell carcinoma

Indexed keywords

EID: 84920448838     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195149616.003.0032     Document Type: Chapter

References (156)

1. Ahlborg G, Hogstedt C, Sundell L, Aman CG. 1981. Laryngeal cancer and pickling house vapors. Scand J Work Environ Health 7:239-240.
2. Almadori G, Cadoni G, Cattani P, et al. 2001. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 7:3988-3993.
3. Altieri A, Bosetti C, Talamini R, et al. 2002. Cessation of smoking and drinking and the risk of laryngeal cancer. Br J Cancer 87:1227-1229.
4. American Cancer Society. 2005. Cancer Facts & Figures 2005. American Cancer Society, Inc., Atlanta, GA.
5. Assimakopoulos D, Patrikakos G. 2002. The role of gastroesophageal reflux in the pathogenesis of laryngeal carcinoma. Am J Otolaryngol 23:351-357.
6. Austin DF, Reynolds P. 1996. Laryngeal cancer. In: Schottenfeld D, Faumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. Oxford University Press, pp. 619-636.
7. Bagnardi V, Biangiardo M, La Vecchia C, Corrao G. 2001. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:1700-1705.
8. Baron AE, Franceschi S, Barra S, Talamini R, La Vecchia C. 1993. A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 2:519-523.
9. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. 2000. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28.
10. Berrino F, Richiardi L, Boffetta P, et al. 2003. Occupation and larynx and hypopharynx cancer: A job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control 14:213-223.
11. Boffetta P, Richiardi L, Berrino F, et al. 2003. Occupation and larynx and hypopharynx cancer: An international case-control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 14:203-212.
12. Borras E, Coutelle C, Rosell A, et al. 2000. Genetic polymorphism of alcohol dehydrogenase in europeans: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 31:984-989.
13. Bosetti C, Gallus S, Franceschi S, et al. 2002a. Cancer of the larynx in nonsmoking alcohol drinkers and in non-drinking tobacco smokers. Br J Cancer 87:516-518.
14. Bosetti C, La Vecchia C, Talamini R, et al. 2002b. Food groups and laryngeal cancer Risk: A case-control study from Italy and Switzerland. Int J Cancer 100:355-360.
15. Bouquot JE, Gnepp DR. 1991a. Laryngeal precancer: A review of the literature, commentary, and comparison with oral leukoplakia. Head Neck 13:488-497.
16. Bouquot JE, Weiland LH, Kurland LT. 1991b. Laryngeal keratosis and carcinoma in the Rochester, Minnesota population, 1935-1984. Cancer Detect Prev 5:83-91.
17. Boyle JO, Mao L, Brennan JA, et al. 1994. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 168:429-432.
18. Boyle P, Zheng T, Macfarlane GJ, et al. 1990. Recent advances in the etiology and epidemiology of head and neck cancer. Curr Opin Oncol 2:539-545.
19. Brennan JA, Boyle JO, Koch WM, et al. 1995. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 332:712-717.
20. Brennan P, Lewis S, Hashibe M, et al. 2004. Pooled-analysis of alcohol dehydrogenase genotypes and head and neck cancer-a HuGE review. Am J Epidemiol 159:1-16.
21. Burch JD, Howe GR, Miller AB, Semenciw R. 1981. Tobacco, alcohol, asbestos, and nickel in the etiology of cancer of the larynx: A case-control study. J Natl Cancer Inst 67:1219-1224.
22. Califano J, van der Riet P, Westra W, et al. 1996. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56:2488-2492.
23. Caporaso N, Goldstein A. 1995. Cancer genes: single and susceptibility: Exposing the difference. Pharmacogenetics 5:59-63.
24. Carey TE, Van Dyke DL, Worsham MJ. 1993. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res 13:2561-2567.
25. Cascorbi I, Henning S, Brockmoller J, et al. 2000. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res 60:644-649.
26. Chan CK, Gee BL. 1988. Asbestos exposure and laryngeal cancer: An analysis of the epidemiologic evidence. J Occup Med 30:23-27.
27. Cooper MP, Jovanovic A, Nauta JJP, et al. 1995. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 121:157-160.
28. De Stefani E, Boffetta P, Oreggia F, et al. 2000a. Plant foods and risk of laryngeal cancer: A case-control study in Uruguay. Int J Cancer 87:129-132.
29. De Stefani E, Boffetta P, Oreggia F, Ronco A, Kogevinas M, Mendilaharsu M. 1998a. Occupation and the risk of laryngeal cancer in Uruguay. Am J Ind Med 33:537-542.
30. De Stefani E, Correa P, Oreggia F, et al. 1987. Risk factors for laryngeal cancer. Cancer 60:3087-3091.
31. De Stefani E, Oreggia F, Rivero S, Fierro L. 1992. Hand-rolled cigarette smoking and risk of cancer of the mouth, pharynx, and larynx. Cancer 70:679-682.
32. De Stefani E, Ronco A, Mendilaharsu M, Deneo-Pellegrini H. 1998b. A case-control study on the role of heterocyclic amines in the etiology of upper digestive cancers in Uruguay. Nutr Cancer 32:43-8.
33. De Stefani E, Oreggia F, Boffetta P, Deneo-Pellegrini H, Ronco A, Mendilaharsu M. 2000b. Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: A case-control in Uruguay. Oral Oncol 36:47-53.
34. Doll R, Peto J. 1985. Effects on Health of Exposure to Asbestos. London:Health and Safety Commission: Her Majesty's Stationery Office.
35. Dosemeci M, Gokmen I, Unsal M, Hayes RB, Blair A. 1997. Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey. Cancer Causes Control 8:729-737.
36. Dyson N, Howley PM, Munger K, Harlow E. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-936.
37. Edenberg HJ and Bosron WF. 1997. Alcohol dehydrogenases. In: Guengerich FP, ed. Comprehensive Toxicology. Vol 3: Biotransformation. New York: Pergamon Press, pp. 119-131.
38. Edelman DA. 1989. Laryngeal cancer and occupational exposure to asbestos. Int Arch Occup Environ Health 61:223-227.
39. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. 2002. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 23:1229-1234.
40. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. 2001. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 96:2013-2018.
41. Elwood JM, Pearson JC, Skippen DH, Jackson SM. 1984. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer 34:603-612.
42. Esteve J, Riboli E, Pequignot G, et al. 1996. Diet and cancers of the larynx and hypopharynx: The IARC multi-center study in southwestern Europe. Cancer Causes Control 7:240-252.
43. Falk RT, Pickle LW, Brown LM, Mason TJ, Buffler PA, Fraumeni JF. 1989. Effect of smoking and alcohol consumption on laryngeal cancer risk in coastal Texas. Cancer Res 49:4024-4029.
44. Ferlay J, Bray F, Pisani P, Parkin DM. 2001. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer-Base No. 5. Lyon, IARC Press.
45. Flanders WD, Rothman KJ. 1982. Interaction of alcohol and tobacco in laryngeal cancer. Am J Epidemiol 115:371-379.
46. Fliss MS, Usadel H, Caballero OL, et al. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019.
47. Foulkes WD, Brunet J-S, Kowalski LP, Narod SA, Franco EL. 1995. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: A casecontrol study. Int J Cancer 63:769-773.
48. Franceschi S, Munoz N, Snijders PJ. 2000. How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet 356:871-872.
49. Franceschi S, Talamini R, Barra S, et al. 1990. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in Northern Italy. Cancer Res 50:6502-6507.
50. Freudenheim JL, Graham S, Byers TE, et al. 1992. Diet, smoking, and alcohol in cancer of the larynx: A case-control study. Nutr Cancer 17:33-45.
51. Fritz A, Percy C, Jack A, et al., eds. 2000. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization.
52. Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C. 2003. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev 12:514-517.
53. Geisler SA, Olshan AF. 2001. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A mini-huge review. Am J Epidemiol 154:95-105.
54. Gencik A, Wey W, Muller H. 1986. High incidence of laryngeal carcinoma in a Swiss family. J Otorhinolaryngol Relat Spec 48:162-166.
55. Gillison ML, Koch WM, Capone RB, et al. 2000. Evidence for a casual association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720.
56. Gillison ML, Shah KV. 2001. Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13:183-188.
57. Go C, Schwartz MR, Donovan DT. 2003. Molecular transformation of recurrent respiratory papillomatosis: Viral typing and p53 overexpression. Ann Otol Rhinol Laryngol 112:298-302.
58. Goldberg M, Goldberg P, Leclerc A, Chastang JF, Marne MJ, Dubourdieu D. 1994. A 10-year incidence survey of respiratory cancer and a case-control study within a cohort of nickel mining and refining workers in New Caledonia. Cancer Causes Control 5:15-25.
59. Goldberg P, Leclerc A, Luce D, Morcet J-F, Brugère J. 1997. Laryngeal and hypopharyngeal cancer and occupation: Results of a case-controls study. Occup Environ Med 54:477-482.
60. Goldstein AM, Blot WJ, Greenberg RS, et al. 1994. Familial risk in oral and pharyngeal cancer. Eur J Cancer B Oral Oncol 30B: 319-322.
61. Goode EL, Ulrich CM, Potter JD. 2002. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530.
62. Goodman M, Morgan RW, Ray R, Malloy CD, Zhao K. 1999. Cancer in asbestos-exposed occupational cohorts: A meta-analysis. Cancer Causes Control 10:453-465.
63. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
64. Grove AD, Llewellyn GC, Kessler FK, White KL Jr, Crespi CL, Ritter JK. 2000. Differential protection by rat UDP-glucuronosyltransferase 1A7 against Benzo [a] pyrene-3, 6-quinone-versus Benzo [a] pyrene-induced cytotoxic effects in human lymphoblastoid cells. Toxicol Appl Pharmacol 162:34-43.
65. Guenel P, Chastang JF, Luce D, Leclerc A, Brugere J. 1988. A study of the interaction of alcohol drinking and tobacco smoking among French cases of laryngeal cancer. J Epidemiol Commun Health 42:350-354.
66. Gustavsson P, Jakobsson R, Johansson H, Lewin F, Norell S, Rutkvist L-E. 1997. Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: A case-control study in Sweden. Occup Environ Med 55:393-400.
67. Ha PK, Califano JA. 2002. The molecular biology of laryngeal cancer. Otolaryngol Clin N Am 35:993-1012.
68. Ha PK, Pai SI, Westra WH, et al. 2002. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8:1203-1209.
69. Hecht SS, Hoffmann D. 1988. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9:875-884.
70. Hedberg K, Vaughan TL, White E, Davis S, Thomas DB. 1994. Alcoholism and cancer of the larynx: A case-control study in western Washington (United States). Cancer Causes Control 5:3-8.
71. Hong WK, Endicott J, Itri LM, et al. 1986. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-1505.
72. Hong WK, Lippman SM, Itri LM, et al. 1990. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795-801.
73. Hu YC, Sidransky D, Ahrendt SA. 2002. Molecular detection approaches for smoking associated tumors. Oncogene 21:7289-7297.
74. IARC. 1986. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 38: Tobacco Smoking. Lyon: International Agency for Research on Cancer.
75. IARC. 1988. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 44: Alcohol Drinking. Lyon: International Agency for Research on Cancer.
76. IARC. 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 62: Wood dust and formaldehyde. Lyon: International Agency for Research on Cancer.
77. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. 2000. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 60:534-536.
78. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. 1999. Glutathione Stransferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol Biomarkers Prev 8:185-188.
79. Jusawalla DJ, Deshpande VA. 1971. Evaluation of cancer risk in tobacco chewers and smokers: An epidemiologic assessment. Cancer 28:244-252.
80. Katoh T, Kaneko S, Kohshi K, et al. 1999. Genetic polymorphisms of tobacco-and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 83:606-609.
81. Kim ES, Hong WK, Khuri FR. 2002. Chemoprevention of aerodigestive tract cancers. Annu Rev Med 53:223-243.
82. La Vecchia C, Negri E, D'Avanzo B, Franceschi S, Decarli A, Boyle P. 1990. Dietary indicators of laryngeal cancer risk. Cancer Res 50:4497-4500.
83. Lazarus P, Park JY. 2000. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol 36:421-431.
84. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. 1999. Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994. Eur J Cancer 30:1477-1516.
85. Liddell FDK. 1990. Laryngeal cancer and asbestos. Br J Ind Med 47:289-291.
86. Lie ES, Engh V, Boysen M, et al. 1994. Squamous cell carcinoma of the respiratory tract following laryngeal papillomatosis. Acta Otolaryngol 114:209-212.
87. Lindeberg H, Elbrond O. 1990. Laryngeal papillomas: The epidemiology in a Danish subpopulation 1965-1984. Clin Otolaryngol 15:125-131.
88. Lindeberg H, Krogdahl A. 1999. Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 146:9-13.
89. Lopez-Abente G, Pollan M, Monge V, Martinezvidal A. 1992. Tobacco smoking, alcohol consumption, and laryngeal cancer in Madrid. Cancer Detect Prev 16:265-271.
90. Lynch J, Hanis NM, Bird MG, Murray KJ, Walsh JP. 1979. An association of upper respiratory cancer with exposure to diethyl sulfate. J Occup Med 211:333-341.
91. Magnus K, Andersen A, Hogetveit AC. 1982. Cancer of respiratory organs among workers at a nickel refinery in Norway. Int J Cancer 30:681-685.
92. Maier H, De Vries N, Snow GB. 1991. Occupational factors in the aetiology of head and neck cancer. Clin Otolaryngol 16:406-412.
93. Maier H, Dietz A, Gewelke U, Heller W-D, Weidauer H. 1992. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 70:320-327.
94. Manning KP, Skegg DCG, Stell PM, Doll R. 1981. Cancer of the larynx and other occupational hazards of mustard gas workers. Clin Otolaryngol 6:165-170.
95. Marchand JL, Luce D, Leclerc A, et al. 2000. Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: Results of a casecontrol study. Am J Ind Med 37:581-589.
96. Matthias C, Bockmuhl U, Jahnke V, et al. 1998. The glutathione S-transferase GSTP1 polymorphism: Effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 8:1-6.
97. McKaig RG, Baric RS, Olshan AF. 1998. Human papillomavirus and head and neck cancer: Epidemiology and molecular biology. Head Neck 20:250-265.
98. Morita S, Yano M, Tsujinaka T, et al. 1999. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 80:685-688.
99. Mork J, Lie K, Glattre E, et al. 2001. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125-1131.
100. Muller KM, Krohn BR. 1980. Smoking habits and their relationship to precancerous lesions of the larynx. J Cancer Res Clin Oncol 96:211-217.
101. Muscat JE, Wynder EL. 1992. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer 69:2244-2251.
102. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. 1996. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2:1035-1037.
103. Nomura T, Noma H, Shibahara T, Yokoyama A, Muramatusu T, Ohmori T. 2000. Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol 36:42-46.
104. Olsen J, Sabreo S, Fasting U. 1985. Interaction of alcohol and tobacco as risk factors in cancer of the laryngeal region. J Epidemiol Community Health 39:165-168.
105. Olshan AF, Weissler MC, Pei H, Conway K. 1997. p53 mutations in head and neck cancer: New data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev 6:499-504.
106. Ono I. 1980. Mass screening for the detection of early carcinoma of the larynx. Nippon Jibiinkoka Gakkai Kaiho 83:1498-1502.
107. Oreggia F, De Stefani E, Boffetta P, Brennan P, Deneo-Pellegrini H, Ronco AL. 2001. Meat, fat and risk of laryngeal cancer: A case-control study in Uruguay. Oral Oncol 37:141-145.
108. Osier MV, Pakstis AJ, Soodyall H, et al. 2002. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet 71:84-99.
109. Papadimitrakopoulou VA, Clayman GL, Shin DM, et al. 1999. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 125:1083-1089.
110. Papadimitrakopoulou VA. 2002. Chemoprevention of head and neck cancer: An update. Curr Opin Oncol 14:318-322.
111. Parkin DM, Bray F, Ferlay J, Pisani P. 2001. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156.
112. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas D, eds. 2002. Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155.
113. Parnes SM. 1990. Asbestos and cancer of the larynx: Is there a relationship? Laryngoscope 100:254-261.
114. Pedersen E, Hogetveit AC, Andersen A. 1973. Cancer of respiratory organs among workers at a nickel refinery in Norway. Int J Cancer 12:32-41.
115. Pelucchi C, Talamini R, Levi F, et al. 2003. Fibre intake and laryngeal cancer risk. Ann Oncol 14:162-167.
116. Percy C, Van Holten V, Muir C, Eds. 1990. International Classification of Diseases for Oncology. 2nd ed. Geneva: World Health Organization.
117. Reed AL, Califano J, Cairns P, et al. 1996. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56:3630-3633.
118. Ren Q, Murphy SE, Zheng Z, Lazarus P. 2000. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferase 2B7 and 1A9. Drug Metab Dispos 28:1352-1360.
119. Renan MJ. 1993. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7:139-146.
120. Riboli E, Kaaks R, Esteve J. 1996. Nutrition and laryngeal cancer. Cancer Causes Control 7:147-156.
121. Rodu B, Cole P. 2002. Smokeless tobacco use and cancer of the upper respiratory tract. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:511-515.
122. Rogers MA, Thomas DB, Davis S, Vaughan TL, Nevissi AE. 1993. A case-control study of element levels and cancer of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 2:305-312.
123. Rosas SL, Koch W, da Costa Carvalho MG, et al. 2001. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61:939-942.
124. Rothman KJ, Greenland S. 1998. Concepts of Interaction, Modern Epidemiology. 2nd ed. Philadelphia: Lippincott Raven, pp. 329-342.
125. Rothman KJ, Cann CI, Flanders D, Fried MP. 1980. Epidemiology of laryngeal cancer. Epidemiol Rev 2:195-209.
126. Rothman KJ, Cann CI, Fried MP. 1989. Carcinogenicity of dark liquor. Am J Public Health 79:1516-1520.
127. Sanchez-Cespedes M, Esteller M, Wu L, et al. 2000. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60:892-895.
128. Sancho-Garnier H, Theobald S. 1993. Black (air-cured) and blond (flue-cured) tobacco and cancer risk. II: Pharynx and larynx cancer. Eur J Cancer 29A: 273-276.
129. Shaheen N, Ransohoff DF. 2002. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review. JAMA 287:1972-1981.
130. Scheffner M, Werness BA, Hulbregste JM, Levine AJ, Howley PT. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
131. Schlecht NF, Franco EL, Pintos J, et al. 1999. Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aero-digestive tract in Brazil. Am J Epidemiol 150:1129-1137.
132. Schlecht NF, Pintos J, Kowalski LP, Franco EL. 2001. Effect of type of alcoholic beverages on the risks of upper aerodigestive tract cancers in Brazil. Cancer Causes Control 12:579-587.
133. Schwartz MR. 1999. Pathology of laryngeal tumors. In: Thawley SE, Panje WR, Batsakis JG, Lindberg RD, eds. Comprehensive Management of Head and Neck Tumors, Vol. 2. 2nd ed. Philadelphia: WB Saunders, pp. 950-978.
134. SEER. 2003. Surveillance, Epidemiology, and End Results (SEER) Program () SEER*Stat Database: Incidence-SEER 9 Regs, Nov 2002 Sub (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.
135. Smith AH, Handley MA, Wood R. 1990. Epidemiological evidence indicates asbestos causes laryngeal cancer. J Occup Med 32:499-507.
136. Smith M. 1986. Genetics of human alcohol and aldehyde dehydrogenases. Adv Hum Genet 15:249-290.
137. Soskolne CL, Zeighami EA, Hanis NM, et al. 1984. Laryngeal cancer and occupational exposure to sulfuric acid. Am J Epidemiol 120:358-369.
138. Steenland K, Schnorr T, Beaumont J, Halperin W, Bloom T. 1988. Incidence of laryngeal cancer and exposure to acid mist. Br J Ind Med 45:766-776.
139. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. 1988. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 40:93-101.
140. Talamini R, Bosetti C, La Vecchia C, et al. 2002. Combined effect of tobacco and alcohol on laryngeal cancer risk: A case-control study. Cancer Causes Control 13:957-964.
141. Thekdi AA, Ferris RL. 2002. Diagnostic assessment of laryngeal cancer. Otolaryngol Clin North Am 35:953-969.
142. Tuyns AJ, Esteve J, Raymond L, et al. 1988. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 41:483-491.
143. Van Dyke ML, Worsham MJ, Benninger MS, et al. 1994. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9:192-206.
144. Van Houten VMM, Snijders PJF, van den Brekel MWM, et al. 2001. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93:232-235.
145. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. 2000. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 60:396-402.
146. Wada S, Nishimoto Y, Miyanishi M, Kambe S. 1968. Mustard gas as a cause of respiratory neoplasia in man. Lancet I:1161-1163.
147. Wortley P, Vaughan TL, Davis S, Morgan MS, Thomas DB. 1992. A case-control study of occupational risk factors for laryngeal cancer. Br J Ind Med 49:837-844.
148. Wynder EL, Bross IJ, Day E. 1956. A study of environmental factors in cancer of the larynx. Cancer 9:86-110.
149. Wynder EL, Covey LS, Mabuchi K, Mushinski M. 1976. Environmental factors in cancer of the larynx: a second look. Cancer 38:1591-1601.
150. Yokoyama A, Muramatsu T, Omori T, et al. 2001. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22:433-439.
151. Yoshida A, Huang IY, Ikawa M. 1984. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci 81:258-261.
152. Yu GP, Zhang ZF, Hsu TC, Spitz MR, Schantz SP. 1999. Family history of cancer, mutagens sensitivity, and increased risk of head and neck cancer. Cancer Lett 146:93-101.
153. Zatonski W, Becher H, Lissowska J, Wahrendorf J. 1991. Tobacco, alcohol, and diet in the etiology of laryngeal cancer: A population-based case-control study. Cancer Causes Control 2:3-10.
154. Zhang Z-F, Morgenstern H, Spitz MR, et al. 1999. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 8:1071-1078.
155. Zheng W, Blot WJ, Shu X-O, et al. 1992. Diet and other risk factors for laryngeal cancer in Shangai, China. Am J Epidemiol 136:178-191.
156. Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P. 2001. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 93:1411-1418.